NEWS - May 25, 2022 Relmada Therapeutics to Present Data at the American Society of Clinical Psychopharmacology 2022 Annual Meeting Read more
NEWS - May 5, 2022 Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results Read more
NEWS - Apr 29, 2022 Relmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Frontiers in Pharmacology Read more
NEWS - Apr 28, 2022 Relmada Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 5, 2022 Read more
NEWS - Apr 4, 2022 Relmada Therapeutics to Present Data at the Ketamine & Related Compounds International Hybrid Conference 2022 Read more
NEWS - Mar 23, 2022 Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results Read more
NEWS - Mar 16, 2022 Relmada Therapeutics to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 23, 2022 Read more
NEWS - Mar 10, 2022 Relmada Therapeutics to Participate in Fireside Chats at Two Upcoming Healthcare Events Read more
NEWS - Feb 23, 2022 Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs Ketamine for Abuse Potential Read more
NEWS - Feb 10, 2022 Relmada Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference Read more
